AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35148868 — intervention group
Group type: EXPERIMENTAL
Intervention: Culinary nutrition education intervention
Number of subjects: 83
Study 34939083 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage targeted minimum loss-based estimator
Number of subjects: 0
Study 34939083 — intervention group
Group type: COMPARATOR
Intervention: Existing CRT estimators
Number of subjects: 0
Study 36235571 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g erythritol
Number of subjects: 20
Study 36235571 — intervention group
Group type: COMPARATOR
Intervention: 33.5 g sucrose
Number of subjects: 20
Study 36235571 — intervention group
Group type: COMPARATOR
Intervention: 0.0558 g sucralose
Number of subjects: 20
Study 36235571 — intervention group
Group type: COMPARATOR
Intervention: Tap water
Number of subjects: 20
Study 32578066 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid group (hydrocortisone 500 mg before hepatic pedicle clamping, followed by 300 mg on POD 1, 200 mg on POD 2, and 100 mg on POD 3)
Number of subjects: 94
Study 32578066 — intervention group
Group type: COMPARATOR
Intervention: Control group (physiologic saline)
Number of subjects: 94
Study 32578066 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid group
Number of subjects: 94
Study 32578066 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 94
Study 32396288 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training 3 times per week (G3x)
Number of subjects: 39
Study 32396288 — intervention group
Group type: COMPARATOR
Intervention: Resistance training 2 times per week (G2x)
Number of subjects: 39
Study 32396288 — intervention group
Group type: EXPERIMENTAL
Intervention: Both G2x and G3x
Number of subjects: 39
Study 33185816 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Message Service (SMS)
Number of subjects: 797
Study 33185816 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice Messages (VMS)
Number of subjects: 797
Study 33185816 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 VMS per week
Number of subjects: 797
Study 33185816 — intervention group
Group type: EXPERIMENTAL
Intervention: Other frequencies (not specified)
Number of subjects: 797
Study 33185816 — intervention group
Group type: EXPERIMENTAL
Intervention: Future programs participation
Number of subjects: 797
Study 32458450 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal administration of mother's milk (OPAMM) prior to gavage feeding (0.2 mL of mother's milk before each feeding)
Number of subjects: 40
Study 32458450 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal administration of mother's milk (OPAMM) prior to gavage feeding
Number of subjects: 40
Study 32458450 — intervention group
Group type: COMPARATOR
Intervention: Regular gavage feeding
Number of subjects: 40
Study 32770776 — intervention group
Group type: EXPERIMENTAL
Intervention: New model using PAPP-A measurements and maternal characteristics
Number of subjects: 60875
Study 32770776 — intervention group
Group type: COMPARATOR
Intervention: NICE guidelines
Number of subjects: 60875
Study 35728781 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (500 mg azithromycin for 1 dose and 2 g cefazolin every 8 hours for up to 3 doses)
Number of subjects: 101
Study 35728781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 35728781 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (in class III obesity subgroup)
Number of subjects: 101
Study 35728781 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in class III obesity subgroup)
Number of subjects: 101
Study 34107968 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model developed using multivariate logistic regression from training set (n = 616)
Number of subjects: 880
Study 32277384 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial support (up to 3 weekly financial transfers of $200 each)
Number of subjects: 46
Study 32277384 — intervention group
Group type: COMPARATOR
Intervention: Control group (no financial support)
Number of subjects: 46
Study 35536764 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat (40 mg or 80 mg once daily)
Number of subjects: 6190
Study 35536764 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol (titrated in 100‐mg increments from 200‐400 mg or 300‐600 mg)
Number of subjects: 6190
Study 32701826 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise
Number of subjects: 55
Study 32701826 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise
Number of subjects: 55
Study 32659235 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline RALE score
Number of subjects: 135
Study 32659235 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in RALE score over time
Number of subjects: 135
Study 35303474 — intervention group
Group type: EXPERIMENTAL
Intervention: Two midwives during the second stage of labour
Number of subjects: 3776
Study 35303474 — intervention group
Group type: COMPARATOR
Intervention: One midwife during the second stage of labour
Number of subjects: 3776
Study 33036058 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% hyaluronic acid
Number of subjects: 20
Study 33036058 — intervention group
Group type: COMPARATOR
Intervention: 0.1% hyaluronic acid
Number of subjects: 20
Study 33036058 — intervention group
Group type: COMPARATOR
Intervention: 0.2% hyaluronic acid
Number of subjects: 20
Study 36148748 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin D3 supplementation (400 IU/day)
Number of subjects: 80
Study 36148748 — intervention group
Group type: COMPARATOR
Intervention: Sunlight exposure (40% body surface area for a minimum of 30 minutes/week)
Number of subjects: 80
Study 33497912 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training intervention
Number of subjects: 50
Study 33497912 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster sessions
Number of subjects: 50
Study 33497912 — intervention group
Group type: COMPARATOR
Intervention: Entropy-based metric
Number of subjects: 50
Study 33189807 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate coronary angiography
Number of subjects: 522
Study 33189807 — intervention group
Group type: COMPARATOR
Intervention: Delayed coronary angiography
Number of subjects: 522
Study 33189807 — intervention group
Group type: EXPERIMENTAL
Intervention: Significant coronary artery disease (CAD) in women
Number of subjects: 522
Study 33189807 — intervention group
Group type: EXPERIMENTAL
Intervention: Significant coronary artery disease (CAD) in men
Number of subjects: 522
Study 35968706 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Rhythm Control (ERC)
Number of subjects: 1093
Study 35968706 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 1093
Study 33725800 — intervention group
Group type: EXPERIMENTAL
Intervention: dupilumab
Number of subjects: 0
Study 33725800 — intervention group
Group type: EXPERIMENTAL
Intervention: topical pimecrolimus
Number of subjects: 0
Study 33725800 — intervention group
Group type: EXPERIMENTAL
Intervention: topical tacrolimus
Number of subjects: 0
Study 33725800 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 36074631 — intervention group
Group type: EXPERIMENTAL
Intervention: Power up Children's Psychological Immunity (PCPI)
Number of subjects: 87
Study 36074631 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 87
Study 32275730 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer tutoring program
Number of subjects: 376
Study 32275730 — intervention group
Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 376
Study 36029727 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm pre-eclampsia
Number of subjects: 44
Study 34163067 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-calorie diet
Number of subjects: 0
Study 34163067 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-diet microbiota transplantation to mice
Number of subjects: 0
Study 34163067 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 0
Study 36201753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 33358263 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 0
Study 33358263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32030636 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation program (1-hour sessions per week for 8 weeks)
Number of subjects: 20
Study 32030636 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 20
Study 32008370 — intervention group
Group type: EXPERIMENTAL
Intervention: EjS‐PVP (Ejaculatory hood‐sparing photoselective vaporization of the prostate)
Number of subjects: 27
Study 32008370 — intervention group
Group type: EXPERIMENTAL
Intervention: EjS‐BPVP (Ejaculatory hood‐sparing bipolar button plasma vaporization of the prostate)
Number of subjects: 27
Study 32008370 — intervention group
Group type: COMPARATOR
Intervention: EjS‐PVP
Number of subjects: 27
Study 32008370 — intervention group
Group type: COMPARATOR
Intervention: EjS‐BPVP
Number of subjects: 27
Study 32008370 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 27
Study 36173627 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up of abnormal cancer screening test results
Number of subjects: 275
Study 36173627 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up of overdue abnormal cancer screening test results
Number of subjects: 275
Study 36173627 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with managing abnormal cancer screening test results
Number of subjects: 275
Study 36173627 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to follow-up of abnormal cancer screening test results
Number of subjects: 275
Study 34109485 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain connectivity markers identified using diffusion tensor imaging and resting-state functional MRI
Number of subjects: 131
Study 34109485 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest model constructed from the training group
Number of subjects: 131
Study 34109485 — intervention group
Group type: COMPARATOR
Intervention: Five of nine markers
Number of subjects: 131
Study 32819132 — intervention group
Group type: EXPERIMENTAL
Intervention: ALBI score
Number of subjects: 529
Study 32819132 — intervention group
Group type: EXPERIMENTAL
Intervention: MELD score
Number of subjects: 529
Study 32819132 — intervention group
Group type: EXPERIMENTAL
Intervention: CLIF-C ACLF score
Number of subjects: 529
Study 34114408 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhengyuan capsule (8-week regimen)
Number of subjects: 0
Study 34114408 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule (8-week regimen)
Number of subjects: 0
Study 32539805 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiotherapy (SABR) followed by L19-IL2 therapy for oligo-metastatic patients; SABR to one (symptomatic) to a maximum of 5 lesions for poly-metastatic patients.
Number of subjects: 126
Study 32539805 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiotherapy (SABR) combined with immunotherapy (L19-IL2).
Number of subjects: 126
Study 32539805 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) according to local protocol.
Number of subjects: 126
Study 32082008 — intervention group
Group type: EXPERIMENTAL
Intervention: Labor Epidural Analgesia (EA)
Number of subjects: 0
Study 32082008 — intervention group
Group type: COMPARATOR
Intervention: Labor Spinal Analgesia (SA)
Number of subjects: 0
Study 34417708 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in work hours
Number of subjects: 187
Study 34131733 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal insulin
Number of subjects: 10
Study 34131733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 32385720 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% turmeric powder diet
Number of subjects: 5
Study 32385720 — intervention group
Group type: EXPERIMENTAL
Intervention: 14% turmeric powder diet
Number of subjects: 5
Study 32385720 — intervention group
Group type: COMPARATOR
Intervention: 0% turmeric powder diet (control)
Number of subjects: 5
Study 36414402 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard cancer care plus in-home palliative care
Number of subjects: 95
Study 36414402 — intervention group
Group type: COMPARATOR
Intervention: Standard cancer care
Number of subjects: 95
Study 34636853 — intervention group
Group type: EXPERIMENTAL
Intervention: UV‐C light plus standard environmental cleaning
Number of subjects: 302
Study 34636853 — intervention group
Group type: COMPARATOR
Intervention: Standard environmental cleaning
Number of subjects: 302
Study 33371058 — intervention group
Group type: COMPARATOR
Intervention: Low-dose meropenem (1g IV every 8 hours)
Number of subjects: 64
Study 33371058 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose meropenem (2g IV every 8 hours)
Number of subjects: 64
Study 35465002 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing care in operating room combined with intraoperative heat preservation intervention
Number of subjects: 200
Study 35465002 — intervention group
Group type: COMPARATOR
Intervention: Nursing care in operating room
Number of subjects: 200
Study 33847098 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary-supplemented artichoke (Cynara scolymus L.) at 3g/kg in the diet of laying hens.
Number of subjects: 80
Study 33847098 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving 130 g/day of compound feed for laying hens without artichoke supplementation.
Number of subjects: 80
Study 32242355 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent endoscopy within 6 hours after gastroenterologic consultation
Number of subjects: 516
Study 32242355 — intervention group
Group type: COMPARATOR
Intervention: Early endoscopy between 6 and 24 hours after gastroenterologic consultation
Number of subjects: 516
Study 32242355 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent endoscopy within 6 hours
Number of subjects: 516
Study 32242355 — intervention group
Group type: COMPARATOR
Intervention: Early endoscopy between 6 and 24 hours
Number of subjects: 516
Study 35709412 — intervention group
Group type: EXPERIMENTAL
Intervention: Four cycles of ifosfamide, vincristine, and actinomycin D (IVA) plus doxorubicin, five cycles of IVA, and 12 cycles of maintenance chemotherapy (low-dose cyclophosphamide and vinorelbine).
Number of subjects: 270
Study 35709412 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of bevacizumab to the same chemotherapy (in BERNIE study).
Number of subjects: 270
Study 35709412 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ≤ 2 Oberlin risk factors (ORFs).
Number of subjects: 270
Study 32450793 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD) days
Number of subjects: 195
Study 32450793 — intervention group
Group type: COMPARATOR
Intervention: First non-HD days (>24 to ≤48 h after start HD)
Number of subjects: 195
Study 32450793 — intervention group
Group type: COMPARATOR
Intervention: Second non-HD days (>48 to ≤72 h after start HD)
Number of subjects: 195
Study 32450793 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-h post-HD
Number of subjects: 195
Study 34752913 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 or 25mg with standard of care (SOC)
Number of subjects: 0
Study 34752913 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 0
Study 34076901 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin 12 mg once daily for 3 days plus standard care
Number of subjects: 164
Study 34076901 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone for 14 days
Number of subjects: 164
Study 32080000 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal ketamine
Number of subjects: 1102
Study 32080000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1102
Study 34343735 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface contact laser‐turbinectomy and NSB reduction using a 970 nm diode laser (Group 1)
Number of subjects: 39
Study 34343735 — intervention group
Group type: COMPARATOR
Intervention: Laser‐turbinectomy without NSB reduction (Group 2)
Number of subjects: 39
Study 34060937 — intervention group
Group type: EXPERIMENTAL
Intervention: MET409 (farnesoid X receptor agonist)
Number of subjects: 48
Study 34060937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 34060937 — intervention group
Group type: EXPERIMENTAL
Intervention: MET409
Number of subjects: 48
Study 36231156 — intervention group
Group type: EXPERIMENTAL
Intervention: Speak Up Be Safe (SUBS) curriculum
Number of subjects: 2797
Study 36231156 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2797
Study 32958468 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise therapy and patient education (8-week program)
Number of subjects: 16499
Study 33023488 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriflunomide 14 mg
Number of subjects: 0
Study 33023488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36185085 — intervention group
Group type: EXPERIMENTAL
Intervention: Hewei Jiangni Decoction (HWJND) 81 g plus dummy omeprazole 20 mg daily for 8 weeks
Number of subjects: 128
Study 36185085 — intervention group
Group type: COMPARATOR
Intervention: Dummy HWJND granules (81 g) plus omeprazole (20 mg)
Number of subjects: 128
Study 32847567 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Bunnell suture technique (group B)
Number of subjects: 72
Study 32847567 — intervention group
Group type: COMPARATOR
Intervention: Bundle-to-bundle suture technique (group A)
Number of subjects: 72
Study 32847567 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study 36242061 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangyi Qiangshen Gong exercise prescription (KQG)
Number of subjects: 60
Study 36242061 — intervention group
Group type: COMPARATOR
Intervention: World Health Organization instructed breathing techniques (BT)
Number of subjects: 60
Study 34974512 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) distraction
Number of subjects: 20
Study 34974512 — intervention group
Group type: COMPARATOR
Intervention: iPad distraction (active control)
Number of subjects: 20
Study 34974512 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear (across both groups)
Number of subjects: 20
Study 35535708 — intervention group
Group type: EXPERIMENTAL
Intervention: Methenamine hippurate (1g twice daily)
Number of subjects: 240
Study 36042251 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus rhamnosus HN001
Number of subjects: 0
Study 36042251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32301701 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: 250 mL of 0.9% normal saline containing 2 g cefuroxime sodium 30 minutes before surgery
Number of subjects: 486
Study 32301701 — intervention group
Group type: COMPARATOR
Intervention: Group C: cefuroxime only after returning to ward, once daily for 3 consecutive days
Number of subjects: 486
Study 32301701 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: cefuroxime 30 minutes before surgery and 3 days after surgery
Number of subjects: 486
Study 33359042 — intervention group
Group type: EXPERIMENTAL
Intervention: At-home treatment with 10% carbamide peroxide (2 h/day; 3 weeks)
Number of subjects: 130
Study 33359042 — intervention group
Group type: EXPERIMENTAL
Intervention: In-office treatment with 35% hydrogen peroxide (1/week; 3 weeks)
Number of subjects: 130
Study 33359042 — intervention group
Group type: COMPARATOR
Intervention: At-home placebo
Number of subjects: 130
Study 33359042 — intervention group
Group type: COMPARATOR
Intervention: In-office placebo
Number of subjects: 130
Study 35794366 — intervention group
Group type: EXPERIMENTAL
Intervention: HW-CO2
Number of subjects: 85
Study 35794366 — intervention group
Group type: COMPARATOR
Intervention: DC-CO2
Number of subjects: 85
Study 34020445 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive weight loss lifestyle intervention based on an energy-restricted Mediterranean diet and physical activity promotion
Number of subjects: 362
Study 34020445 — intervention group
Group type: COMPARATOR
Intervention: Non-energy-restricted Mediterranean diet
Number of subjects: 362
Study 34020445 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive weight loss lifestyle intervention
Number of subjects: 362
Study 34020445 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention groups
Number of subjects: 362
Study 36855259 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) for 4 weeks, 3 sessions per week
Number of subjects: 19
Study 36855259 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 19
Study 33108521 — intervention group
Group type: EXPERIMENTAL
Intervention: Cod (750 g/week)
Number of subjects: 76
Study 33108521 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmon (750 g/week)
Number of subjects: 76
Study 33108521 — intervention group
Group type: COMPARATOR
Intervention: Control (no fish intake)
Number of subjects: 76
Study 36206046 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intervention messaging (6 patient‐centered messages)
Number of subjects: 49138
Study 36206046 — intervention group
Group type: COMPARATOR
Intervention: Control group (no digital intervention messaging)
Number of subjects: 49138
Study 36206046 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intervention messaging (at least 2 completed messages)
Number of subjects: 49138
Study 36206046 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intervention messaging (among White participants)
Number of subjects: 49138
Study 36206046 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intervention messaging (among people of color)
Number of subjects: 49138
Study 33419086 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimizing Background Infusion Mode (OBIM)
Number of subjects: 204
Study 33419086 — intervention group
Group type: COMPARATOR
Intervention: Traditional Background Infusion Mode (TBIM)
Number of subjects: 204
Study 34711225 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Imagery (MI) rehearsal exercise prior to physical practice (n=9)
Number of subjects: 17
Study 34711225 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MI process prior to surgery practice) (n=8)
Number of subjects: 17